PFS
TRML

Prospera Financial Services’s Tourmaline Bio TRML Stock Holding History

Prospera Financial Services’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,397
Closed -$26.3K – 1076
2023
Q1 		$26.3K Sell
1,397
-2,156
-61% -$35.6K ﹤0.01% 947
2022
Q4 		$36.2K Buy
3,553
+2,258
+174% +$36.3K ﹤0.01% 884
2022
Q3 		$34K Buy
+1,295
New +$47.2K ﹤0.01% 822
2022
Q2 		– Sell
-506
Closed -$50K – 2539
2022
Q1 		$50K Buy
+506
New +$47.4K ﹤0.01% 1384

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Prospera Financial Services's TRML Position: Q2 2023 in Review

Prospera Financial Services sold out of Tourmaline Bio (TRML) in Q2 2023, closing a stake of 1,397 shares — an estimated $26.3K sold.

Prospera Financial Services first reported a position in TRML in Q1 2022 and held it in 4 quarters. The position peaked at $50K in Q1 2022. 58 funds tracked by Wall St. Rank hold TRML as of Q2 2023.

  • Prospera Financial Services reported no remaining Tourmaline Bio position as of Q2 2023 after selling out during the quarter.
  • Prospera Financial Services sold 1,397 Tourmaline Bio shares in Q2 2023, an estimated $26.3K.
  • Prospera Financial Services first reported a position in Tourmaline Bio in Q1 2022 and held it in 4 quarters.
  • Prospera Financial Services's Tourmaline Bio position peaked at $50K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2023.

Based on Prospera Financial Services's 13F filing for Q2 2023, filed 8 Aug 2023.